Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 11, 1996

View Archived Issues

Pharma Mar describes cytotoxic xenicane diterpenes

Knoll claims potential anticonvulsants

LG Chemical describes novel vaccine adjuvant formulation

HMR describes NK1/NK2 antagonists for respiratory indications

Antitumor borneol esters reported by Schering AG

cGMP-PDE inhibitors revealed by Fujisawa

New neurotensin receptor ligands from Sanofi

New IGF-I variant disclosed by P&U

Allelix reports thrombospondin-derived antihemorrhagic peptide

Alliance Pharmaceutical: Annual Report 1996

Antithrombin III advances to phase II

Positive results of fomivirsen in the treatment of CMV retinitis

Cholesterol-lowering statin approved in first markets

DepoTech files IND for DepoMorphine

Medarex to acquire Houston Biotechnology

Warfarin underused for stroke prevention

EntreMed in-licenses angiogenesis inhibitor

FDA gives go-ahead to Hemagen for lupus diagnostic

Signal acquires rights to novel signaling proteins

Positive IDEC-C2B8 phase III trial results announced

Genset announces prostate cancer program discoveries

Milestone reached in Cubist/BMS antiinfective drug collaboration

Scotia drug shows excellent activity in cancer patients with cachexia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...